awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69C
Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69C
A phase I study of cabozantinib (XL184) in patients with renal cell cancer.
P2860
Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38430335-0D734EB8-35C1-4312-80CF-47E6DA9DA69C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a742793731ff159d8eb9274f3516738b313f88e4
P2860
Targeting the Met signaling pathway in renal cancer.